N. Horeweg

发表

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

H. D. de Koning, K. Nackaerts, C. Weenink, 2014, The Lancet. Oncology.

Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

H. D. de Koning, K. Nackaerts, C. Weenink, 2013, American journal of respiratory and critical care medicine.

An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.

J. Jett, D. Midthun, C. Powell, 2015, American journal of respiratory and critical care medicine.

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Harry J de Koning, Rozemarijn Vliegenthart, Matthijs Oudkerk, 2014, The Lancet. Oncology.

P. Koper, A. Crijns, C. Marijnen, 2021, Breast Cancer Research and Treatment.

P. Koper, C. Marijnen, C. Marijnen, 2019, Breast.

Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?

B. van Ginneken, H. Gietema, H. D. de Koning, 2014, European Respiratory Journal.

Non-specialist palliative care - question prompt list preparation: patient, family and clinician experiences

N. Horeweg, J. T. van der Steen, A. Pieterse, 2022, BMJ supportive & palliative care.

Detection and quantification of the solid component in pulmonary subsolid nodules by semiautomatic segmentation

B. Ginneken, H. Gietema, M. Prokop, 2015, European Radiology.

THE ROLE OF A CONVENTIONAL BRONCHOSCOPY IN THE WORK-UP OF SUSPICIOUS CT SCREEN DETECTED PULMONARY NODULES

R. Vernhout, K. Nackaerts, C. Weenink, 2011 .

Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial.

K. Nackaerts, C. Weenink, J. Lammers, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial

H. D. de Koning, K. Nackaerts, C. Weenink, 2013, European Respiratory Journal.

End-of-Life Trajectories of Patients With Hematological Malignancies and Patients With Advanced Solid Tumors Visiting the Emergency Department: The Need for a Proactive Integrated Care Approach

C. Marijnen, A. Fogteloo, N. Horeweg, 2019, The American journal of hospice & palliative care.

Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy

A. Pica, C. Rasch, S. V. van Duinen, 2021, Cancers.

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

H. Mackay, Naveena Singh, T. Bosse, 2020, Cancers.

Assessment of patient symptom burden and information needs helps tailoring palliative care consultations: An observational study

A. C. Valkenburg, Y. M. van der Linden, N. Horeweg, 2022, European journal of cancer care.

Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer

N. Horeweg, R. Nout, C. Creutzberg, 2020, International Journal of Gynecological Cancer.

Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials.

T. Bosse, E. M. van der Steen-Banasik, V. Smit, 2022, Gynecologic oncology.

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

P. Pollock, C. Genestie, H. Kitchener, 2022, Modern Pathology.

Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review.

M. Hoogeman, S. D. de Boer, N. Horeweg, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System

S. H. van der Burg, H. Putter, M. Hoogeman, 2021, Cancers.

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

C. Genestie, H. Mackay, A. Fyles, 2022, British Journal of Cancer.

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program

J. Ledermann, T. Bosse, N. Singh, 2022, International Journal of Gynecological Cancer.

Management of conjunctival melanoma with local excision and adjuvant brachytherapy

M. Hulshof, S. V. van Duinen, G. Luyten, 2020, Eye.

Ruthenium-106 brachytherapy for iris and iridociliary melanomas

G. Luyten, N. Horeweg, J. Bleeker, 2017, British Journal of Ophthalmology.

The self-perceived palliative care barriers and educational needs of clinicians working in hospital primary care teams and referral patterns: lessons learned from a single-center survey and cohort study.

Y. M. van der Linden, N. Horeweg, S. Luelmo, 2021, Annals of palliative medicine.

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

T. Bosse, S. D. de Boer, N. Horeweg, 2020, International Journal of Gynecological Cancer.

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

Harry J de Koning, Mathias Prokop, Rozemarijn Vliegenthart, 2020, The New England journal of medicine.

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

H. Putter, T. Bosse, D. Cibula, 2020, International Journal of Gynecological Cancer.

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

H. Putter, C. Haie-meder, P. Pollock, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment.

T. Bosse, N. T. Ter Haar, V. Smit, 2022, Gynecologic oncology.

Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.

H. Mackay, J. Dijkstra, T. Bosse, 2022, The Lancet. Digital health.

Vaginal brachytherapy management of stage I and II endometrial cancer

N. Horeweg, R. Nout, C. Creutzberg, 2022, International Journal of Gynecological Cancer.

Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer

B. Gilks, T. Bosse, V. Smit, 2021, Histopathology.

Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer

K. Mertz, T. Bosse, E. M. van der Steen-Banasik, 2020, Cancer Immunology Research.

A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer.

N. Horeweg, R. Nout, I. Boere, 2022, Critical reviews in oncology/hematology.

Adjuvant Systemic Therapy after Chemoradiation and Brachytherapy for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis

N. Horeweg, R. Nout, I. Boere, 2021, Cancers.

The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning

T. Bosse, N. Horeweg, V. Koelzer, 2022, Frontiers in Oncology.

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer

H. Putter, T. Bosse, L. Mileshkin, 2021, Journal of the National Cancer Institute.

Interscan variation of semi-automated volumetry of subsolid pulmonary nodules

B. Ginneken, H. Gietema, M. Prokop, 2014, European Radiology.

The importance of screening for lung cancer

H. D. de Koning, N. Horeweg, N. Horeweg, 2014, Expert review of respiratory medicine.

Low-dose computed tomography screening for lung cancer: results of the first screening round.

H. D. de Koning, K. Nackaerts, M. Oudkerk, 2013, Journal of Comparative Effectiveness Research.

Palliative care needs of advanced cancer patients in the emergency department at the end of life: an observational cohort study

Y. M. van der Linden, N. Horeweg, M. Fiocco, 2019, Supportive Care in Cancer.

The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules.

H. D. de Koning, R. Vernhout, K. Nackaerts, 2012, Chest.

Automated causal inference in application to randomized controlled clinical trials pdf

Viktor H. Koelzer, Tjalling Bosse, Remi A. Nout, 2022, Nature Machine Intelligence.

Blinded and uniform cause of death verification in a lung cancer CT screening trial.

H. D. de Koning, K. Nackaerts, C. Weenink, 2012, Lung cancer.

Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening

M. Oudkerk, R. Vliegenthart, W. Mali, 2014, European Radiology.

595 Implementation of collaborative translational research (TransPORTEC) findings in an international endometrial cancer clinical trials program (RAINBO)

T. Bosse, L. Mileshkin, N. Horeweg, 2021, Endometrial cancer.

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

H. Mackay, T. Bosse, L. Mileshkin, 2021, Nature Communications.

Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer

N. Horeweg, V. Coen, E. Kerkhof, 2019, International Journal of Gynecologic Cancer.

Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study

M. Oudkerk, N. Horeweg, C. van der Aalst, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma

C. Rasch, J. Beenakker, G. Luyten, 2022, Neuroradiology.

QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

J. Khattra, J. McAlpine, C. Gilks, 2023, JCO global oncology.

Interpretable Deep Learning Predicts the Molecular Endometrial Cancer Classification from H&E Images: A Combined Analysis of the Portec Randomized Clinical Trials

H. Mackay, J. Dijkstra, T. Bosse, 2022, SSRN Electronic Journal.

Accelerated Partial Breast Irradiation using External-Beam or Intraoperative Electron Radiotherapy: 5 year oncological outcomes of a prospective cohort study.

P. Koper, C. Marijnen, M. Straver, 2022, International journal of radiation oncology, biology, physics.

Reply: stage distribution of lung cancers detected by computed tomography screening in the NELSON Trial.

H. D. de Koning, N. Horeweg, 2013, American journal of respiratory and critical care medicine.

Correction Method for Optical Scaling of Fundoscopy Images: Development, Validation, and First Implementation

N. Horeweg, Gwyneth A. van Rijn, Luc van Vught, 2024, Investigative ophthalmology & visual science.

Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.

L. Sommers, G. Luyten, N. Horeweg, 2016, European journal of cancer.

397 Molecular profiling of NSMP high-risk endometrial cancers of the PORTEC-3 trial – prognostic refinement and druggable targets

A. Leary, N. Horeweg, P. Bessette, 2021, Endometrial cancer.

Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE.

N. Horeweg, Venkatesh Pai, K. Tanderup, 2024, International journal of radiation oncology, biology, physics.